Global Equine Rabies Immunoglobulin (ERIG) Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Equine Rabies Immunoglobulin (ERIG) market size was valued at US$ million in 2023. With growing demand in downstream market, the Equine Rabies Immunoglobulin (ERIG) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Equine Rabies Immunoglobulin (ERIG) market. Equine Rabies Immunoglobulin (ERIG) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Equine Rabies Immunoglobulin (ERIG). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Equine Rabies Immunoglobulin (ERIG) market.
Equine rabies immunoglobulin (ERIG) is a biological product derived from horse blood plasma used as passive immunity against rabies virus.
The market for equine rabies immunoglobulin is driven by its role as a protective treatment for rabies exposure, especially in regions where human rabies immune globulin (HRIG) may not be readily available. ERIG is used in combination with the rabies vaccine to prevent rabies infection. As rabies prevention remains a priority in animal healthcare and public health, the market for ERIG is expected to continue.
Key Features:
The report on Equine Rabies Immunoglobulin (ERIG) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Equine Rabies Immunoglobulin (ERIG) market. It may include historical data, market segmentation by Type (e.g., 1500IU, 1000IU), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Equine Rabies Immunoglobulin (ERIG) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Equine Rabies Immunoglobulin (ERIG) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Equine Rabies Immunoglobulin (ERIG) industry. This include advancements in Equine Rabies Immunoglobulin (ERIG) technology, Equine Rabies Immunoglobulin (ERIG) new entrants, Equine Rabies Immunoglobulin (ERIG) new investment, and other innovations that are shaping the future of Equine Rabies Immunoglobulin (ERIG).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Equine Rabies Immunoglobulin (ERIG) market. It includes factors influencing customer ' purchasing decisions, preferences for Equine Rabies Immunoglobulin (ERIG) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Equine Rabies Immunoglobulin (ERIG) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Equine Rabies Immunoglobulin (ERIG) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Equine Rabies Immunoglobulin (ERIG) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Equine Rabies Immunoglobulin (ERIG) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Equine Rabies Immunoglobulin (ERIG) market.
Market Segmentation:
Equine Rabies Immunoglobulin (ERIG) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Equine Rabies Immunoglobulin (ERIG) market?
What factors are driving Equine Rabies Immunoglobulin (ERIG) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Equine Rabies Immunoglobulin (ERIG) market opportunities vary by end market size?
How does Equine Rabies Immunoglobulin (ERIG) break out type, application?
According to our LPI (LP Information) latest study, the global Equine Rabies Immunoglobulin (ERIG) market size was valued at US$ million in 2023. With growing demand in downstream market, the Equine Rabies Immunoglobulin (ERIG) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Equine Rabies Immunoglobulin (ERIG) market. Equine Rabies Immunoglobulin (ERIG) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Equine Rabies Immunoglobulin (ERIG). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Equine Rabies Immunoglobulin (ERIG) market.
Equine rabies immunoglobulin (ERIG) is a biological product derived from horse blood plasma used as passive immunity against rabies virus.
The market for equine rabies immunoglobulin is driven by its role as a protective treatment for rabies exposure, especially in regions where human rabies immune globulin (HRIG) may not be readily available. ERIG is used in combination with the rabies vaccine to prevent rabies infection. As rabies prevention remains a priority in animal healthcare and public health, the market for ERIG is expected to continue.
Key Features:
The report on Equine Rabies Immunoglobulin (ERIG) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Equine Rabies Immunoglobulin (ERIG) market. It may include historical data, market segmentation by Type (e.g., 1500IU, 1000IU), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Equine Rabies Immunoglobulin (ERIG) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Equine Rabies Immunoglobulin (ERIG) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Equine Rabies Immunoglobulin (ERIG) industry. This include advancements in Equine Rabies Immunoglobulin (ERIG) technology, Equine Rabies Immunoglobulin (ERIG) new entrants, Equine Rabies Immunoglobulin (ERIG) new investment, and other innovations that are shaping the future of Equine Rabies Immunoglobulin (ERIG).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Equine Rabies Immunoglobulin (ERIG) market. It includes factors influencing customer ' purchasing decisions, preferences for Equine Rabies Immunoglobulin (ERIG) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Equine Rabies Immunoglobulin (ERIG) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Equine Rabies Immunoglobulin (ERIG) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Equine Rabies Immunoglobulin (ERIG) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Equine Rabies Immunoglobulin (ERIG) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Equine Rabies Immunoglobulin (ERIG) market.
Market Segmentation:
Equine Rabies Immunoglobulin (ERIG) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- 1500IU
- 1000IU
- 400IU
- Other
- Category II Exposure
- Category III Exposure
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Serum China
- Lanzhou Institute of Biological Products
- Wuhan Institute of Biological Products
- Premium Serums
- Haffkine Bio-Pharmaceutical
- Bharat Serums
What is the 10-year outlook for the global Equine Rabies Immunoglobulin (ERIG) market?
What factors are driving Equine Rabies Immunoglobulin (ERIG) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Equine Rabies Immunoglobulin (ERIG) market opportunities vary by end market size?
How does Equine Rabies Immunoglobulin (ERIG) break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Equine Rabies Immunoglobulin (ERIG) Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Equine Rabies Immunoglobulin (ERIG) by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Equine Rabies Immunoglobulin (ERIG) by Country/Region, 2019, 2023 & 2030
2.2 Equine Rabies Immunoglobulin (ERIG) Segment by Type
2.2.1 1500IU
2.2.2 1000IU
2.2.3 400IU
2.2.4 Other
2.3 Equine Rabies Immunoglobulin (ERIG) Sales by Type
2.3.1 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2019-2024)
2.3.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue and Market Share by Type (2019-2024)
2.3.3 Global Equine Rabies Immunoglobulin (ERIG) Sale Price by Type (2019-2024)
2.4 Equine Rabies Immunoglobulin (ERIG) Segment by Application
2.4.1 Category II Exposure
2.4.2 Category III Exposure
2.5 Equine Rabies Immunoglobulin (ERIG) Sales by Application
2.5.1 Global Equine Rabies Immunoglobulin (ERIG) Sale Market Share by Application (2019-2024)
2.5.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue and Market Share by Application (2019-2024)
2.5.3 Global Equine Rabies Immunoglobulin (ERIG) Sale Price by Application (2019-2024)
3 GLOBAL EQUINE RABIES IMMUNOGLOBULIN (ERIG) BY COMPANY
3.1 Global Equine Rabies Immunoglobulin (ERIG) Breakdown Data by Company
3.1.1 Global Equine Rabies Immunoglobulin (ERIG) Annual Sales by Company (2019-2024)
3.1.2 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Company (2019-2024)
3.2 Global Equine Rabies Immunoglobulin (ERIG) Annual Revenue by Company (2019-2024)
3.2.1 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Company (2019-2024)
3.2.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Company (2019-2024)
3.3 Global Equine Rabies Immunoglobulin (ERIG) Sale Price by Company
3.4 Key Manufacturers Equine Rabies Immunoglobulin (ERIG) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Equine Rabies Immunoglobulin (ERIG) Product Location Distribution
3.4.2 Players Equine Rabies Immunoglobulin (ERIG) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR EQUINE RABIES IMMUNOGLOBULIN (ERIG) BY GEOGRAPHIC REGION
4.1 World Historic Equine Rabies Immunoglobulin (ERIG) Market Size by Geographic Region (2019-2024)
4.1.1 Global Equine Rabies Immunoglobulin (ERIG) Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Equine Rabies Immunoglobulin (ERIG) Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Equine Rabies Immunoglobulin (ERIG) Market Size by Country/Region (2019-2024)
4.2.1 Global Equine Rabies Immunoglobulin (ERIG) Annual Sales by Country/Region (2019-2024)
4.2.2 Global Equine Rabies Immunoglobulin (ERIG) Annual Revenue by Country/Region (2019-2024)
4.3 Americas Equine Rabies Immunoglobulin (ERIG) Sales Growth
4.4 APAC Equine Rabies Immunoglobulin (ERIG) Sales Growth
4.5 Europe Equine Rabies Immunoglobulin (ERIG) Sales Growth
4.6 Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales Growth
5 AMERICAS
5.1 Americas Equine Rabies Immunoglobulin (ERIG) Sales by Country
5.1.1 Americas Equine Rabies Immunoglobulin (ERIG) Sales by Country (2019-2024)
5.1.2 Americas Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2019-2024)
5.2 Americas Equine Rabies Immunoglobulin (ERIG) Sales by Type
5.3 Americas Equine Rabies Immunoglobulin (ERIG) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Equine Rabies Immunoglobulin (ERIG) Sales by Region
6.1.1 APAC Equine Rabies Immunoglobulin (ERIG) Sales by Region (2019-2024)
6.1.2 APAC Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2019-2024)
6.2 APAC Equine Rabies Immunoglobulin (ERIG) Sales by Type
6.3 APAC Equine Rabies Immunoglobulin (ERIG) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Equine Rabies Immunoglobulin (ERIG) by Country
7.1.1 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2019-2024)
7.1.2 Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2019-2024)
7.2 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Type
7.3 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Equine Rabies Immunoglobulin (ERIG) by Country
8.1.1 Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales by Country (2019-2024)
8.1.2 Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2019-2024)
8.2 Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales by Type
8.3 Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Equine Rabies Immunoglobulin (ERIG)
10.3 Manufacturing Process Analysis of Equine Rabies Immunoglobulin (ERIG)
10.4 Industry Chain Structure of Equine Rabies Immunoglobulin (ERIG)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Equine Rabies Immunoglobulin (ERIG) Distributors
11.3 Equine Rabies Immunoglobulin (ERIG) Customer
12 WORLD FORECAST REVIEW FOR EQUINE RABIES IMMUNOGLOBULIN (ERIG) BY GEOGRAPHIC REGION
12.1 Global Equine Rabies Immunoglobulin (ERIG) Market Size Forecast by Region
12.1.1 Global Equine Rabies Immunoglobulin (ERIG) Forecast by Region (2025-2030)
12.1.2 Global Equine Rabies Immunoglobulin (ERIG) Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Equine Rabies Immunoglobulin (ERIG) Forecast by Type
12.7 Global Equine Rabies Immunoglobulin (ERIG) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Serum China
13.1.1 Serum China Company Information
13.1.2 Serum China Equine Rabies Immunoglobulin (ERIG) Product Portfolios and Specifications
13.1.3 Serum China Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Serum China Main Business Overview
13.1.5 Serum China Latest Developments
13.2 Lanzhou Institute of Biological Products
13.2.1 Lanzhou Institute of Biological Products Company Information
13.2.2 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Portfolios and Specifications
13.2.3 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Lanzhou Institute of Biological Products Main Business Overview
13.2.5 Lanzhou Institute of Biological Products Latest Developments
13.3 Wuhan Institute of Biological Products
13.3.1 Wuhan Institute of Biological Products Company Information
13.3.2 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Portfolios and Specifications
13.3.3 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Wuhan Institute of Biological Products Main Business Overview
13.3.5 Wuhan Institute of Biological Products Latest Developments
13.4 Premium Serums
13.4.1 Premium Serums Company Information
13.4.2 Premium Serums Equine Rabies Immunoglobulin (ERIG) Product Portfolios and Specifications
13.4.3 Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Premium Serums Main Business Overview
13.4.5 Premium Serums Latest Developments
13.5 Haffkine Bio-Pharmaceutical
13.5.1 Haffkine Bio-Pharmaceutical Company Information
13.5.2 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Product Portfolios and Specifications
13.5.3 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Haffkine Bio-Pharmaceutical Main Business Overview
13.5.5 Haffkine Bio-Pharmaceutical Latest Developments
13.6 Bharat Serums
13.6.1 Bharat Serums Company Information
13.6.2 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Product Portfolios and Specifications
13.6.3 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Bharat Serums Main Business Overview
13.6.5 Bharat Serums Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Equine Rabies Immunoglobulin (ERIG) Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Equine Rabies Immunoglobulin (ERIG) by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Equine Rabies Immunoglobulin (ERIG) by Country/Region, 2019, 2023 & 2030
2.2 Equine Rabies Immunoglobulin (ERIG) Segment by Type
2.2.1 1500IU
2.2.2 1000IU
2.2.3 400IU
2.2.4 Other
2.3 Equine Rabies Immunoglobulin (ERIG) Sales by Type
2.3.1 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2019-2024)
2.3.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue and Market Share by Type (2019-2024)
2.3.3 Global Equine Rabies Immunoglobulin (ERIG) Sale Price by Type (2019-2024)
2.4 Equine Rabies Immunoglobulin (ERIG) Segment by Application
2.4.1 Category II Exposure
2.4.2 Category III Exposure
2.5 Equine Rabies Immunoglobulin (ERIG) Sales by Application
2.5.1 Global Equine Rabies Immunoglobulin (ERIG) Sale Market Share by Application (2019-2024)
2.5.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue and Market Share by Application (2019-2024)
2.5.3 Global Equine Rabies Immunoglobulin (ERIG) Sale Price by Application (2019-2024)
3 GLOBAL EQUINE RABIES IMMUNOGLOBULIN (ERIG) BY COMPANY
3.1 Global Equine Rabies Immunoglobulin (ERIG) Breakdown Data by Company
3.1.1 Global Equine Rabies Immunoglobulin (ERIG) Annual Sales by Company (2019-2024)
3.1.2 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Company (2019-2024)
3.2 Global Equine Rabies Immunoglobulin (ERIG) Annual Revenue by Company (2019-2024)
3.2.1 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Company (2019-2024)
3.2.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Company (2019-2024)
3.3 Global Equine Rabies Immunoglobulin (ERIG) Sale Price by Company
3.4 Key Manufacturers Equine Rabies Immunoglobulin (ERIG) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Equine Rabies Immunoglobulin (ERIG) Product Location Distribution
3.4.2 Players Equine Rabies Immunoglobulin (ERIG) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR EQUINE RABIES IMMUNOGLOBULIN (ERIG) BY GEOGRAPHIC REGION
4.1 World Historic Equine Rabies Immunoglobulin (ERIG) Market Size by Geographic Region (2019-2024)
4.1.1 Global Equine Rabies Immunoglobulin (ERIG) Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Equine Rabies Immunoglobulin (ERIG) Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Equine Rabies Immunoglobulin (ERIG) Market Size by Country/Region (2019-2024)
4.2.1 Global Equine Rabies Immunoglobulin (ERIG) Annual Sales by Country/Region (2019-2024)
4.2.2 Global Equine Rabies Immunoglobulin (ERIG) Annual Revenue by Country/Region (2019-2024)
4.3 Americas Equine Rabies Immunoglobulin (ERIG) Sales Growth
4.4 APAC Equine Rabies Immunoglobulin (ERIG) Sales Growth
4.5 Europe Equine Rabies Immunoglobulin (ERIG) Sales Growth
4.6 Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales Growth
5 AMERICAS
5.1 Americas Equine Rabies Immunoglobulin (ERIG) Sales by Country
5.1.1 Americas Equine Rabies Immunoglobulin (ERIG) Sales by Country (2019-2024)
5.1.2 Americas Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2019-2024)
5.2 Americas Equine Rabies Immunoglobulin (ERIG) Sales by Type
5.3 Americas Equine Rabies Immunoglobulin (ERIG) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Equine Rabies Immunoglobulin (ERIG) Sales by Region
6.1.1 APAC Equine Rabies Immunoglobulin (ERIG) Sales by Region (2019-2024)
6.1.2 APAC Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2019-2024)
6.2 APAC Equine Rabies Immunoglobulin (ERIG) Sales by Type
6.3 APAC Equine Rabies Immunoglobulin (ERIG) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Equine Rabies Immunoglobulin (ERIG) by Country
7.1.1 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2019-2024)
7.1.2 Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2019-2024)
7.2 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Type
7.3 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Equine Rabies Immunoglobulin (ERIG) by Country
8.1.1 Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales by Country (2019-2024)
8.1.2 Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2019-2024)
8.2 Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales by Type
8.3 Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Equine Rabies Immunoglobulin (ERIG)
10.3 Manufacturing Process Analysis of Equine Rabies Immunoglobulin (ERIG)
10.4 Industry Chain Structure of Equine Rabies Immunoglobulin (ERIG)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Equine Rabies Immunoglobulin (ERIG) Distributors
11.3 Equine Rabies Immunoglobulin (ERIG) Customer
12 WORLD FORECAST REVIEW FOR EQUINE RABIES IMMUNOGLOBULIN (ERIG) BY GEOGRAPHIC REGION
12.1 Global Equine Rabies Immunoglobulin (ERIG) Market Size Forecast by Region
12.1.1 Global Equine Rabies Immunoglobulin (ERIG) Forecast by Region (2025-2030)
12.1.2 Global Equine Rabies Immunoglobulin (ERIG) Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Equine Rabies Immunoglobulin (ERIG) Forecast by Type
12.7 Global Equine Rabies Immunoglobulin (ERIG) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Serum China
13.1.1 Serum China Company Information
13.1.2 Serum China Equine Rabies Immunoglobulin (ERIG) Product Portfolios and Specifications
13.1.3 Serum China Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Serum China Main Business Overview
13.1.5 Serum China Latest Developments
13.2 Lanzhou Institute of Biological Products
13.2.1 Lanzhou Institute of Biological Products Company Information
13.2.2 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Portfolios and Specifications
13.2.3 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Lanzhou Institute of Biological Products Main Business Overview
13.2.5 Lanzhou Institute of Biological Products Latest Developments
13.3 Wuhan Institute of Biological Products
13.3.1 Wuhan Institute of Biological Products Company Information
13.3.2 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Portfolios and Specifications
13.3.3 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Wuhan Institute of Biological Products Main Business Overview
13.3.5 Wuhan Institute of Biological Products Latest Developments
13.4 Premium Serums
13.4.1 Premium Serums Company Information
13.4.2 Premium Serums Equine Rabies Immunoglobulin (ERIG) Product Portfolios and Specifications
13.4.3 Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Premium Serums Main Business Overview
13.4.5 Premium Serums Latest Developments
13.5 Haffkine Bio-Pharmaceutical
13.5.1 Haffkine Bio-Pharmaceutical Company Information
13.5.2 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Product Portfolios and Specifications
13.5.3 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Haffkine Bio-Pharmaceutical Main Business Overview
13.5.5 Haffkine Bio-Pharmaceutical Latest Developments
13.6 Bharat Serums
13.6.1 Bharat Serums Company Information
13.6.2 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Product Portfolios and Specifications
13.6.3 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Bharat Serums Main Business Overview
13.6.5 Bharat Serums Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Equine Rabies Immunoglobulin (ERIG) Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Equine Rabies Immunoglobulin (ERIG) Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 1500IU
Table 4. Major Players of 1000IU
Table 5. Major Players of 400IU
Table 6. Major Players of Other
Table 7. Global Equine Rabies Immunoglobulin (ERIG) Sales by Type (2019-2024) & (Kiloton)
Table 8. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2019-2024)
Table 9. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2019-2024) & ($ million)
Table 10. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2019-2024)
Table 11. Global Equine Rabies Immunoglobulin (ERIG) Sale Price by Type (2019-2024) & (US$/Ton)
Table 12. Global Equine Rabies Immunoglobulin (ERIG) Sales by Application (2019-2024) & (Kiloton)
Table 13. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2019-2024)
Table 14. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2019-2024)
Table 15. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2019-2024)
Table 16. Global Equine Rabies Immunoglobulin (ERIG) Sale Price by Application (2019-2024) & (US$/Ton)
Table 17. Global Equine Rabies Immunoglobulin (ERIG) Sales by Company (2019-2024) & (Kiloton)
Table 18. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Company (2019-2024)
Table 19. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Company (2019-2024)
Table 21. Global Equine Rabies Immunoglobulin (ERIG) Sale Price by Company (2019-2024) & (US$/Ton)
Table 22. Key Manufacturers Equine Rabies Immunoglobulin (ERIG) Producing Area Distribution and Sales Area
Table 23. Players Equine Rabies Immunoglobulin (ERIG) Products Offered
Table 24. Equine Rabies Immunoglobulin (ERIG) Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Equine Rabies Immunoglobulin (ERIG) Sales by Geographic Region (2019-2024) & (Kiloton)
Table 28. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share Geographic Region (2019-2024)
Table 29. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Equine Rabies Immunoglobulin (ERIG) Sales by Country/Region (2019-2024) & (Kiloton)
Table 32. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country/Region (2019-2024)
Table 33. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Equine Rabies Immunoglobulin (ERIG) Sales by Country (2019-2024) & (Kiloton)
Table 36. Americas Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2019-2024)
Table 37. Americas Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2019-2024)
Table 39. Americas Equine Rabies Immunoglobulin (ERIG) Sales by Type (2019-2024) & (Kiloton)
Table 40. Americas Equine Rabies Immunoglobulin (ERIG) Sales by Application (2019-2024) & (Kiloton)
Table 41. APAC Equine Rabies Immunoglobulin (ERIG) Sales by Region (2019-2024) & (Kiloton)
Table 42. APAC Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2019-2024)
Table 43. APAC Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2019-2024)
Table 45. APAC Equine Rabies Immunoglobulin (ERIG) Sales by Type (2019-2024) & (Kiloton)
Table 46. APAC Equine Rabies Immunoglobulin (ERIG) Sales by Application (2019-2024) & (Kiloton)
Table 47. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2019-2024) & (Kiloton)
Table 48. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2019-2024)
Table 49. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2019-2024)
Table 51. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Type (2019-2024) & (Kiloton)
Table 52. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Application (2019-2024) & (Kiloton)
Table 53. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales by Country (2019-2024) & (Kiloton)
Table 54. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales by Type (2019-2024) & (Kiloton)
Table 58. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales by Application (2019-2024) & (Kiloton)
Table 59. Key Market Drivers & Growth Opportunities of Equine Rabies Immunoglobulin (ERIG)
Table 60. Key Market Challenges & Risks of Equine Rabies Immunoglobulin (ERIG)
Table 61. Key Industry Trends of Equine Rabies Immunoglobulin (ERIG)
Table 62. Equine Rabies Immunoglobulin (ERIG) Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Equine Rabies Immunoglobulin (ERIG) Distributors List
Table 65. Equine Rabies Immunoglobulin (ERIG) Customer List
Table 66. Global Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Region (2025-2030) & (Kiloton)
Table 67. Global Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Country (2025-2030) & (Kiloton)
Table 69. Americas Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Region (2025-2030) & (Kiloton)
Table 71. APAC Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Country (2025-2030) & (Kiloton)
Table 73. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Country (2025-2030) & (Kiloton)
Table 75. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Type (2025-2030) & (Kiloton)
Table 77. Global Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Application (2025-2030) & (Kiloton)
Table 79. Global Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Serum China Basic Information, Equine Rabies Immunoglobulin (ERIG) Manufacturing Base, Sales Area and Its Competitors
Table 81. Serum China Equine Rabies Immunoglobulin (ERIG) Product Portfolios and Specifications
Table 82. Serum China Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 83. Serum China Main Business
Table 84. Serum China Latest Developments
Table 85. Lanzhou Institute of Biological Products Basic Information, Equine Rabies Immunoglobulin (ERIG) Manufacturing Base, Sales Area and Its Competitors
Table 86. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Portfolios and Specifications
Table 87. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 88. Lanzhou Institute of Biological Products Main Business
Table 89. Lanzhou Institute of Biological Products Latest Developments
Table 90. Wuhan Institute of Biological Products Basic Information, Equine Rabies Immunoglobulin (ERIG) Manufacturing Base, Sales Area and Its Competitors
Table 91. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Portfolios and Specifications
Table 92. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 93. Wuhan Institute of Biological Products Main Business
Table 94. Wuhan Institute of Biological Products Latest Developments
Table 95. Premium Serums Basic Information, Equine Rabies Immunoglobulin (ERIG) Manufacturing Base, Sales Area and Its Competitors
Table 96. Premium Serums Equine Rabies Immunoglobulin (ERIG) Product Portfolios and Specifications
Table 97. Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 98. Premium Serums Main Business
Table 99. Premium Serums Latest Developments
Table 100. Haffkine Bio-Pharmaceutical Basic Information, Equine Rabies Immunoglobulin (ERIG) Manufacturing Base, Sales Area and Its Competitors
Table 101. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Product Portfolios and Specifications
Table 102. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 103. Haffkine Bio-Pharmaceutical Main Business
Table 104. Haffkine Bio-Pharmaceutical Latest Developments
Table 105. Bharat Serums Basic Information, Equine Rabies Immunoglobulin (ERIG) Manufacturing Base, Sales Area and Its Competitors
Table 106. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Product Portfolios and Specifications
Table 107. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 108. Bharat Serums Main Business
Table 109. Bharat Serums Latest Developments
Table 1. Equine Rabies Immunoglobulin (ERIG) Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Equine Rabies Immunoglobulin (ERIG) Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 1500IU
Table 4. Major Players of 1000IU
Table 5. Major Players of 400IU
Table 6. Major Players of Other
Table 7. Global Equine Rabies Immunoglobulin (ERIG) Sales by Type (2019-2024) & (Kiloton)
Table 8. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2019-2024)
Table 9. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2019-2024) & ($ million)
Table 10. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2019-2024)
Table 11. Global Equine Rabies Immunoglobulin (ERIG) Sale Price by Type (2019-2024) & (US$/Ton)
Table 12. Global Equine Rabies Immunoglobulin (ERIG) Sales by Application (2019-2024) & (Kiloton)
Table 13. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2019-2024)
Table 14. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2019-2024)
Table 15. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2019-2024)
Table 16. Global Equine Rabies Immunoglobulin (ERIG) Sale Price by Application (2019-2024) & (US$/Ton)
Table 17. Global Equine Rabies Immunoglobulin (ERIG) Sales by Company (2019-2024) & (Kiloton)
Table 18. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Company (2019-2024)
Table 19. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Company (2019-2024)
Table 21. Global Equine Rabies Immunoglobulin (ERIG) Sale Price by Company (2019-2024) & (US$/Ton)
Table 22. Key Manufacturers Equine Rabies Immunoglobulin (ERIG) Producing Area Distribution and Sales Area
Table 23. Players Equine Rabies Immunoglobulin (ERIG) Products Offered
Table 24. Equine Rabies Immunoglobulin (ERIG) Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Equine Rabies Immunoglobulin (ERIG) Sales by Geographic Region (2019-2024) & (Kiloton)
Table 28. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share Geographic Region (2019-2024)
Table 29. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Equine Rabies Immunoglobulin (ERIG) Sales by Country/Region (2019-2024) & (Kiloton)
Table 32. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country/Region (2019-2024)
Table 33. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Equine Rabies Immunoglobulin (ERIG) Sales by Country (2019-2024) & (Kiloton)
Table 36. Americas Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2019-2024)
Table 37. Americas Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2019-2024)
Table 39. Americas Equine Rabies Immunoglobulin (ERIG) Sales by Type (2019-2024) & (Kiloton)
Table 40. Americas Equine Rabies Immunoglobulin (ERIG) Sales by Application (2019-2024) & (Kiloton)
Table 41. APAC Equine Rabies Immunoglobulin (ERIG) Sales by Region (2019-2024) & (Kiloton)
Table 42. APAC Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2019-2024)
Table 43. APAC Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2019-2024)
Table 45. APAC Equine Rabies Immunoglobulin (ERIG) Sales by Type (2019-2024) & (Kiloton)
Table 46. APAC Equine Rabies Immunoglobulin (ERIG) Sales by Application (2019-2024) & (Kiloton)
Table 47. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2019-2024) & (Kiloton)
Table 48. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2019-2024)
Table 49. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2019-2024)
Table 51. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Type (2019-2024) & (Kiloton)
Table 52. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Application (2019-2024) & (Kiloton)
Table 53. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales by Country (2019-2024) & (Kiloton)
Table 54. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales by Type (2019-2024) & (Kiloton)
Table 58. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales by Application (2019-2024) & (Kiloton)
Table 59. Key Market Drivers & Growth Opportunities of Equine Rabies Immunoglobulin (ERIG)
Table 60. Key Market Challenges & Risks of Equine Rabies Immunoglobulin (ERIG)
Table 61. Key Industry Trends of Equine Rabies Immunoglobulin (ERIG)
Table 62. Equine Rabies Immunoglobulin (ERIG) Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Equine Rabies Immunoglobulin (ERIG) Distributors List
Table 65. Equine Rabies Immunoglobulin (ERIG) Customer List
Table 66. Global Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Region (2025-2030) & (Kiloton)
Table 67. Global Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Country (2025-2030) & (Kiloton)
Table 69. Americas Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Region (2025-2030) & (Kiloton)
Table 71. APAC Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Country (2025-2030) & (Kiloton)
Table 73. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Country (2025-2030) & (Kiloton)
Table 75. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Type (2025-2030) & (Kiloton)
Table 77. Global Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Application (2025-2030) & (Kiloton)
Table 79. Global Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Serum China Basic Information, Equine Rabies Immunoglobulin (ERIG) Manufacturing Base, Sales Area and Its Competitors
Table 81. Serum China Equine Rabies Immunoglobulin (ERIG) Product Portfolios and Specifications
Table 82. Serum China Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 83. Serum China Main Business
Table 84. Serum China Latest Developments
Table 85. Lanzhou Institute of Biological Products Basic Information, Equine Rabies Immunoglobulin (ERIG) Manufacturing Base, Sales Area and Its Competitors
Table 86. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Portfolios and Specifications
Table 87. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 88. Lanzhou Institute of Biological Products Main Business
Table 89. Lanzhou Institute of Biological Products Latest Developments
Table 90. Wuhan Institute of Biological Products Basic Information, Equine Rabies Immunoglobulin (ERIG) Manufacturing Base, Sales Area and Its Competitors
Table 91. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Portfolios and Specifications
Table 92. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 93. Wuhan Institute of Biological Products Main Business
Table 94. Wuhan Institute of Biological Products Latest Developments
Table 95. Premium Serums Basic Information, Equine Rabies Immunoglobulin (ERIG) Manufacturing Base, Sales Area and Its Competitors
Table 96. Premium Serums Equine Rabies Immunoglobulin (ERIG) Product Portfolios and Specifications
Table 97. Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 98. Premium Serums Main Business
Table 99. Premium Serums Latest Developments
Table 100. Haffkine Bio-Pharmaceutical Basic Information, Equine Rabies Immunoglobulin (ERIG) Manufacturing Base, Sales Area and Its Competitors
Table 101. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Product Portfolios and Specifications
Table 102. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 103. Haffkine Bio-Pharmaceutical Main Business
Table 104. Haffkine Bio-Pharmaceutical Latest Developments
Table 105. Bharat Serums Basic Information, Equine Rabies Immunoglobulin (ERIG) Manufacturing Base, Sales Area and Its Competitors
Table 106. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Product Portfolios and Specifications
Table 107. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 108. Bharat Serums Main Business
Table 109. Bharat Serums Latest Developments
LIST OF FIGURES
Figure 1. Picture of Equine Rabies Immunoglobulin (ERIG)
Figure 2. Equine Rabies Immunoglobulin (ERIG) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate 2019-2030 (Kiloton)
Figure 7. Global Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Equine Rabies Immunoglobulin (ERIG) Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of 1500IU
Figure 10. Product Picture of 1000IU
Figure 11. Product Picture of 400IU
Figure 12. Product Picture of Other
Figure 13. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type in 2023
Figure 14. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2019-2024)
Figure 15. Equine Rabies Immunoglobulin (ERIG) Consumed in Category II Exposure
Figure 16. Global Equine Rabies Immunoglobulin (ERIG) Market: Category II Exposure (2019-2024) & (Kiloton)
Figure 17. Equine Rabies Immunoglobulin (ERIG) Consumed in Category III Exposure
Figure 18. Global Equine Rabies Immunoglobulin (ERIG) Market: Category III Exposure (2019-2024) & (Kiloton)
Figure 19. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2023)
Figure 20. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application in 2023
Figure 21. Equine Rabies Immunoglobulin (ERIG) Sales Market by Company in 2023 (Kiloton)
Figure 22. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Company in 2023
Figure 23. Equine Rabies Immunoglobulin (ERIG) Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Company in 2023
Figure 25. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Equine Rabies Immunoglobulin (ERIG) Sales 2019-2024 (Kiloton)
Figure 28. Americas Equine Rabies Immunoglobulin (ERIG) Revenue 2019-2024 ($ Millions)
Figure 29. APAC Equine Rabies Immunoglobulin (ERIG) Sales 2019-2024 (Kiloton)
Figure 30. APAC Equine Rabies Immunoglobulin (ERIG) Revenue 2019-2024 ($ Millions)
Figure 31. Europe Equine Rabies Immunoglobulin (ERIG) Sales 2019-2024 (Kiloton)
Figure 32. Europe Equine Rabies Immunoglobulin (ERIG) Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales 2019-2024 (Kiloton)
Figure 34. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Revenue 2019-2024 ($ Millions)
Figure 35. Americas Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country in 2023
Figure 36. Americas Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country in 2023
Figure 37. Americas Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2019-2024)
Figure 38. Americas Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2019-2024)
Figure 39. United States Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region in 2023
Figure 44. APAC Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Regions in 2023
Figure 45. APAC Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2019-2024)
Figure 46. APAC Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2019-2024)
Figure 47. China Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country in 2023
Figure 55. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country in 2023
Figure 56. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2019-2024)
Figure 57. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2019-2024)
Figure 58. Germany Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2019-2024)
Figure 67. Egypt Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Equine Rabies Immunoglobulin (ERIG) in 2023
Figure 73. Manufacturing Process Analysis of Equine Rabies Immunoglobulin (ERIG)
Figure 74. Industry Chain Structure of Equine Rabies Immunoglobulin (ERIG)
Figure 75. Channels of Distribution
Figure 76. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Forecast by Region (2025-2030)
Figure 77. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Equine Rabies Immunoglobulin (ERIG)
Figure 2. Equine Rabies Immunoglobulin (ERIG) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate 2019-2030 (Kiloton)
Figure 7. Global Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Equine Rabies Immunoglobulin (ERIG) Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of 1500IU
Figure 10. Product Picture of 1000IU
Figure 11. Product Picture of 400IU
Figure 12. Product Picture of Other
Figure 13. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type in 2023
Figure 14. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2019-2024)
Figure 15. Equine Rabies Immunoglobulin (ERIG) Consumed in Category II Exposure
Figure 16. Global Equine Rabies Immunoglobulin (ERIG) Market: Category II Exposure (2019-2024) & (Kiloton)
Figure 17. Equine Rabies Immunoglobulin (ERIG) Consumed in Category III Exposure
Figure 18. Global Equine Rabies Immunoglobulin (ERIG) Market: Category III Exposure (2019-2024) & (Kiloton)
Figure 19. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2023)
Figure 20. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application in 2023
Figure 21. Equine Rabies Immunoglobulin (ERIG) Sales Market by Company in 2023 (Kiloton)
Figure 22. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Company in 2023
Figure 23. Equine Rabies Immunoglobulin (ERIG) Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Company in 2023
Figure 25. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Equine Rabies Immunoglobulin (ERIG) Sales 2019-2024 (Kiloton)
Figure 28. Americas Equine Rabies Immunoglobulin (ERIG) Revenue 2019-2024 ($ Millions)
Figure 29. APAC Equine Rabies Immunoglobulin (ERIG) Sales 2019-2024 (Kiloton)
Figure 30. APAC Equine Rabies Immunoglobulin (ERIG) Revenue 2019-2024 ($ Millions)
Figure 31. Europe Equine Rabies Immunoglobulin (ERIG) Sales 2019-2024 (Kiloton)
Figure 32. Europe Equine Rabies Immunoglobulin (ERIG) Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales 2019-2024 (Kiloton)
Figure 34. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Revenue 2019-2024 ($ Millions)
Figure 35. Americas Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country in 2023
Figure 36. Americas Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country in 2023
Figure 37. Americas Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2019-2024)
Figure 38. Americas Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2019-2024)
Figure 39. United States Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region in 2023
Figure 44. APAC Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Regions in 2023
Figure 45. APAC Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2019-2024)
Figure 46. APAC Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2019-2024)
Figure 47. China Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country in 2023
Figure 55. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country in 2023
Figure 56. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2019-2024)
Figure 57. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2019-2024)
Figure 58. Germany Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2019-2024)
Figure 67. Egypt Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Equine Rabies Immunoglobulin (ERIG) Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Equine Rabies Immunoglobulin (ERIG) in 2023
Figure 73. Manufacturing Process Analysis of Equine Rabies Immunoglobulin (ERIG)
Figure 74. Industry Chain Structure of Equine Rabies Immunoglobulin (ERIG)
Figure 75. Channels of Distribution
Figure 76. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Forecast by Region (2025-2030)
Figure 77. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share Forecast by Application (2025-2030)
